Business
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024
Fourth quarter and full year 2024 revenue exceeded guidanceFRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Revenue was $62.3 million, a decrease of 6% from $65.9 million in Q4 2023. Net Loss, inclusive of goodwill impairm
About this update from Definitive Healthcare Corp.
[{"type":"image","alt":"Definitive Healthcare Corp.","displaySize":"","headline":null,"caption":"Definitive Healthcare Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":61,"url":"https://media.zenfs.com/en/globenewswire.com/798d772fd35c853385447e0a83f343de"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/YMii1YNRhhXnoJKWXGC71g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/798d772fd35c853385447e0a83f343de","width":300,"height":61}},"lazy":false},{"type":"text","content":"Fourth quarter and full year 2024 revenue exceeded guidance","length":59,"tagName":"p"},{"type":"text","content":"FRAMINGHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2024.","length":284,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2024 Financial Highlights:","length":41,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue was $62.3 million, a decrease of 6% from $65.9 million in Q4 2023.","length":74,"tagName":"p"}]},{"val":[{"type":"text","content":"Net Loss, inclusive of goodwill impairment charges of $97.1 million, was $(84.7) million, or (136)% of revenue, compared to $(13.4) million or (20)% of revenue in Q4 2023.","length":171,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted Net Income was $12.6 million, compared to $10.6 million in Q4 2023.","length":76,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EBITDA was $17.5 million, or 28% of revenue, compared to $19.8 million, or 30% of revenue in Q4 2023.","length":110,"tagName":"p"}]},{"val":[{"type":"text","content":"Cash Flow from Operations was $8.1 million in the quarter.","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"Unlevered Free Cash Flow was $(1.6) million in the quarter.","length":59,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":548,"olType":false},{"type":"text","content":"Full Year 2024 Financial Highlights:","length":36,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue was $252.2 million, compared to $251.4 million for the full year 2023.","length":78,"tagName":"p"}]},{"val":[{"type"...